MAGNANI, GAIA
 Distribuzione geografica
Continente #
NA - Nord America 1.874
AS - Asia 1.431
EU - Europa 1.382
AF - Africa 91
SA - Sud America 72
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.853
Nazione #
US - Stati Uniti d'America 1.857
SG - Singapore 399
VN - Vietnam 374
CN - Cina 371
GB - Regno Unito 299
IT - Italia 212
DE - Germania 209
SE - Svezia 195
UA - Ucraina 104
HK - Hong Kong 91
FR - Francia 85
RU - Federazione Russa 76
IN - India 65
IE - Irlanda 63
BR - Brasile 50
FI - Finlandia 33
JP - Giappone 32
NL - Olanda 30
ZA - Sudafrica 29
JO - Giordania 25
TG - Togo 24
BG - Bulgaria 22
EE - Estonia 21
PH - Filippine 17
BE - Belgio 11
NG - Nigeria 11
SC - Seychelles 11
AR - Argentina 10
CA - Canada 9
CH - Svizzera 9
BD - Bangladesh 8
TH - Thailandia 8
CI - Costa d'Avorio 7
KR - Corea 7
IR - Iran 6
MX - Messico 6
TW - Taiwan 6
IQ - Iraq 5
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
PL - Polonia 3
PY - Paraguay 3
TR - Turchia 3
UY - Uruguay 3
AU - Australia 2
CL - Cile 2
GR - Grecia 2
KE - Kenya 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
AZ - Azerbaigian 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
JM - Giamaica 1
LY - Libia 1
NO - Norvegia 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
Totale 4.853
Città #
Singapore 273
Southend 259
Ashburn 193
Fairfield 178
Chandler 133
San Jose 111
Hong Kong 90
Wilmington 88
Woodbridge 88
Ho Chi Minh City 83
Seattle 81
Houston 80
Princeton 75
Santa Clara 75
Hanoi 72
Cambridge 65
Dublin 63
Ann Arbor 61
Jacksonville 59
Beijing 50
Boardman 46
New York 44
Nanjing 36
Lauterbourg 32
Bologna 31
Bremen 31
Helsinki 31
Padova 31
Westminster 31
Tokyo 27
Amman 25
Los Angeles 25
Lomé 24
Berlin 23
Shenyang 22
Sofia 22
Dong Ket 21
Turin 20
Jinan 18
Buffalo 17
Dallas 17
Medford 17
Mülheim 16
Frankfurt am Main 15
Haiphong 15
Changsha 13
Milan 13
Hebei 12
Saint Petersburg 12
Abeokuta 11
Brussels 10
Dearborn 10
Guangzhou 10
San Diego 10
Shanghai 10
Da Nang 9
Hefei 9
Jiaxing 9
Munich 9
São Paulo 9
Kuban 8
Nanchang 8
Redondo Beach 8
Abidjan 7
Falkenstein 7
Rome 7
Tianjin 7
Verona 7
Yubileyny 7
Bern 6
Florence 6
Mahé 6
Parma 6
Redmond 6
San Venanzo 6
Taizhou 6
The Dalles 6
Zhengzhou 6
Ancona 5
Council Bluffs 5
Des Moines 5
Haikou 5
Johannesburg 5
Redwood City 5
Reggio Emilia 5
Taiyuan 5
Chicago 4
Kunming 4
London 4
Olalla 4
Bangkok 3
Boston 3
Cebu City 3
Hangzhou 3
Kaohsiung 3
Karachi 3
Merano 3
Mexico City 3
Montreal 3
Nuremberg 3
Totale 3.176
Nome #
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 249
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 200
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 187
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 183
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 181
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 176
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 173
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 169
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 168
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 167
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 162
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 160
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 159
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 159
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 158
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 157
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 156
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 155
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 154
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 154
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 151
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 150
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 149
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 143
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 143
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 139
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 136
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 133
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 131
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 124
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 118
Totale 4.944
Categoria #
all - tutte 12.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 26 12 113
2021/2022578 24 14 34 86 51 27 8 40 20 69 110 95
2022/2023677 71 98 40 85 58 56 14 25 123 26 59 22
2023/2024177 15 36 3 20 2 68 4 2 0 8 8 11
2024/2025640 38 123 57 60 109 33 37 18 1 37 12 115
2025/20261.306 118 94 104 72 186 76 118 84 342 112 0 0
Totale 4.944